Literature DB >> 18230551

Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.

S Metallidis1, D Topsis, J Nikolaidis, E Alexiadou, G Lazaraki, L Grovaris, A Theodoridou, P Nikolaidis.   

Abstract

Penetration of levofloxacin and moxifloxacin into cancellous and cortical bone was studied using high-performance liquid chromatography (HPLC) in 16 patients who underwent routine total hip arthroplasty. Our results demonstrate a good degree of penetration into bone for both quinolones. The mean cancellous penetration was 53.86% for moxifloxacin and 54.13% for levofloxacin. The penetration into cortical bone was 41.59% and 34.26% respectively. The concentrations for both quinolones were above the minimum inhibitory concentration (MIC(90s)) for the most common pathogens, so they can be used for the treatment of osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18230551     DOI: 10.1179/joc.2007.19.6.682

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  9 in total

1.  Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.

Authors:  B Al-Nawas; C Walter; T Morbach; N Seitner; E Siegel; M Maeurer; F Krummenauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

2.  Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.

Authors:  Claudette Muller-Serieys; Azzam Saleh Mghir; Laurent Massias; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

Review 3.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Friedrich F Hennig; Jürgen B Bulitta; Ulrike Holzgrabe; George L Drusano; Fritz Sörgel; Johannes Gusinde
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

5.  Injectability of brushite-forming Mg-substituted and Sr-substituted alpha-TCP bone cements.

Authors:  S Pina; P M C Torres; J M F Ferreira
Journal:  J Mater Sci Mater Med       Date:  2009-10-23       Impact factor: 3.896

Review 6.  Gender analysis of moxifloxacin clinical trials.

Authors:  Elisa Chilet-Rosell; Ma Teresa Ruiz-Cantero; Ma Angeles Pardo
Journal:  J Womens Health (Larchmt)       Date:  2013-11-01       Impact factor: 2.681

7.  Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults.

Authors:  S Esposito; S Leone; M Bassetti; S Borrè; F Leoncini; E Meani; M Venditti; F Mazzotta
Journal:  Infection       Date:  2009-11-10       Impact factor: 7.455

Review 8.  Delafloxacin: design, development and potential place in therapy.

Authors:  Francisco Javier Candel; Marina Peñuelas
Journal:  Drug Des Devel Ther       Date:  2017-03-20       Impact factor: 4.162

9.  Oral Antibiotic Management of Acute Osteomyelitis of the Hand: Outcomes and Cost Comparison to Standard Intravenous Regimen.

Authors:  Mark Henry; Forrest H Lundy
Journal:  Hand (N Y)       Date:  2019-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.